Carta al Editor
Eficacia de tocilizumab en enfermedad de Still del adulto refractaria; a propósito de 2 casos
Efficacy of Tocilizumab in refractory Adult-onset Still's Disease; Report of 2 Cases
Lilia Andrade-Ortega
, Fedra Irazoque-Palazuelos, Sandra Muñoz-López, Victor M. Rosales-Don Pablo
Autor para correspondencia
Servicio de Reumatología, Centro Médico Nacional 20 de Noviembre, ISSSTE, México D.F., México
Leído
18645
Vecesse ha leído el artículo
3420
Total PDF
15225
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 8 | 9 | 17 |
| 2025 5 | 188 | 61 | 249 |
| 2025 4 | 173 | 34 | 207 |
| 2025 3 | 183 | 25 | 208 |
| 2025 2 | 168 | 22 | 190 |
| 2025 1 | 206 | 43 | 249 |
| 2024 12 | 127 | 22 | 149 |
| 2024 11 | 157 | 69 | 226 |
| 2024 10 | 163 | 35 | 198 |
| 2024 9 | 120 | 18 | 138 |
| 2024 8 | 161 | 26 | 187 |
| 2024 7 | 158 | 32 | 190 |
| 2024 6 | 152 | 30 | 182 |
| 2024 5 | 197 | 25 | 222 |
| 2024 4 | 153 | 34 | 187 |
| 2024 3 | 139 | 35 | 174 |
| 2024 2 | 121 | 38 | 159 |
| 2024 1 | 90 | 22 | 112 |
| 2023 12 | 94 | 24 | 118 |
| 2023 11 | 127 | 33 | 160 |
| 2023 10 | 132 | 30 | 162 |
| 2023 9 | 135 | 35 | 170 |
| 2023 8 | 157 | 18 | 175 |
| 2023 7 | 138 | 29 | 167 |
| 2023 6 | 137 | 29 | 166 |
| 2023 5 | 145 | 37 | 182 |
| 2023 4 | 79 | 15 | 94 |
| 2023 3 | 142 | 33 | 175 |
| 2023 2 | 105 | 26 | 131 |
| 2022 1 | 100 | 16 | 116 |
| 2022 12 | 128 | 49 | 177 |
| 2022 11 | 114 | 25 | 139 |
| 2022 10 | 176 | 49 | 225 |
| 2022 9 | 159 | 44 | 203 |
| 2022 8 | 147 | 51 | 198 |
| 2022 7 | 164 | 56 | 220 |
| 2022 6 | 127 | 35 | 162 |
| 2022 5 | 136 | 56 | 192 |
| 2022 4 | 122 | 50 | 172 |
| 2022 3 | 123 | 60 | 183 |
| 2022 2 | 117 | 32 | 149 |
| 2021 1 | 160 | 40 | 200 |
| 2021 12 | 108 | 44 | 152 |
| 2021 11 | 119 | 51 | 170 |
| 2021 10 | 156 | 60 | 216 |
| 2021 9 | 139 | 52 | 191 |
| 2021 8 | 148 | 32 | 180 |
| 2021 7 | 124 | 41 | 165 |
| 2021 6 | 136 | 46 | 182 |
| 2021 5 | 123 | 50 | 173 |
| 2021 4 | 251 | 86 | 337 |
| 2021 3 | 161 | 33 | 194 |
| 2021 2 | 149 | 26 | 175 |
| 2020 1 | 139 | 37 | 176 |
| 2020 12 | 147 | 19 | 166 |
| 2020 11 | 146 | 24 | 170 |
| 2020 10 | 138 | 17 | 155 |
| 2020 9 | 220 | 30 | 250 |
| 2020 8 | 192 | 25 | 217 |
| 2020 7 | 220 | 21 | 241 |
| 2020 6 | 149 | 27 | 176 |
| 2020 5 | 134 | 26 | 160 |
| 2020 4 | 151 | 23 | 174 |
| 2020 3 | 149 | 30 | 179 |
| 2020 2 | 107 | 20 | 127 |
| 2020 1 | 78 | 24 | 102 |
| 2019 12 | 109 | 29 | 138 |
| 2019 11 | 84 | 27 | 111 |
| 2019 10 | 789 | 39 | 828 |
| 2019 9 | 112 | 47 | 159 |
| 2019 8 | 82 | 34 | 116 |
| 2019 7 | 88 | 27 | 115 |
| 2019 6 | 82 | 29 | 111 |
| 2019 5 | 110 | 56 | 166 |
| 2019 4 | 90 | 40 | 130 |
| 2019 3 | 45 | 24 | 69 |
| 2019 2 | 45 | 27 | 72 |
| 2019 1 | 69 | 72 | 141 |
| 2018 12 | 98 | 51 | 149 |
| 2018 11 | 121 | 12 | 133 |
| 2018 10 | 89 | 10 | 99 |
| 2018 9 | 52 | 8 | 60 |
| 2018 8 | 53 | 9 | 62 |
| 2018 7 | 28 | 4 | 32 |
| 2018 6 | 1 | 0 | 1 |
| 2018 5 | 4 | 0 | 4 |
| 2018 4 | 78 | 7 | 85 |
| 2018 3 | 76 | 4 | 80 |
| 2018 2 | 51 | 4 | 55 |
| 2018 1 | 39 | 3 | 42 |
| 2017 12 | 66 | 4 | 70 |
| 2017 11 | 53 | 9 | 62 |
| 2017 10 | 43 | 5 | 48 |
| 2017 9 | 38 | 4 | 42 |
| 2017 8 | 42 | 4 | 46 |
| 2017 7 | 64 | 3 | 67 |
| 2017 6 | 63 | 18 | 81 |
| 2017 5 | 66 | 11 | 77 |
| 2017 4 | 73 | 4 | 77 |
| 2017 3 | 64 | 54 | 118 |
| 2017 2 | 203 | 9 | 212 |
| 2016 1 | 75 | 11 | 86 |
| 2016 12 | 113 | 13 | 126 |
| 2016 11 | 118 | 6 | 124 |
| 2016 10 | 169 | 12 | 181 |
| 2016 9 | 260 | 16 | 276 |
| 2016 8 | 251 | 11 | 262 |
| 2016 7 | 117 | 9 | 126 |
| 2015 12 | 2 | 0 | 2 |
| 2015 9 | 1 | 0 | 1 |
| 2015 8 | 2 | 0 | 2 |
| 2015 7 | 64 | 6 | 70 |
| 2015 6 | 144 | 21 | 165 |
| 2015 5 | 156 | 45 | 201 |
| 2015 4 | 96 | 25 | 121 |
| 2015 3 | 91 | 17 | 108 |
| 2015 2 | 112 | 9 | 121 |
| 2015 1 | 105 | 11 | 116 |
| 2014 12 | 98 | 13 | 111 |
| 2014 11 | 93 | 15 | 108 |
| 2014 10 | 113 | 20 | 133 |
| 2014 9 | 72 | 19 | 91 |
| 2014 8 | 79 | 16 | 95 |
| 2014 7 | 55 | 24 | 79 |
| 2014 6 | 141 | 54 | 195 |
| 2014 5 | 116 | 63 | 179 |
Mostrar todo
